Susquehanna International Group, LLP Gossamer Bio, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 350,961 shares of GOSS stock, worth $259,711. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350,961
Previous 333,594 5.21%
Holding current value
$259,711
Previous $300,000 15.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.79 - $1.25 $13,719 - $21,708
17,367 Added 5.21%
350,961 $347,000
Q2 2024

Aug 15, 2024
SELL
$0.51 - $1.27 $754,193 - $1.88 Million
-1,478,811 Reduced 81.59%
333,594 $300,000
Q1 2024

May 07, 2024
BUY
$0.8 - $1.51 $1.05 Million - $1.98 Million
1,312,583 Added 262.61%
1,812,405 $2.14 Million
Q4 2023

Feb 14, 2024
SELL
$0.48 - $1.08 $30,950 - $69,639
-64,481 Reduced 11.43%
499,822 $454,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $144,829 - $337,935
-185,679 Reduced 24.76%
564,303 $468,000
Q2 2023

Aug 11, 2023
SELL
$0.98 - $1.53 $1.18 Million - $1.85 Million
-1,208,072 Reduced 61.7%
749,982 $899,000
Q1 2023

May 16, 2023
BUY
$0.96 - $2.92 $1.62 Million - $4.93 Million
1,688,552 Added 626.55%
1,958,054 $2.47 Million
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $306,321 - $2.27 Million
176,047 Added 188.38%
269,502 $584,000
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $673,810 - $1.39 Million
93,455 New
93,455 $1.12 Million
Q1 2022

May 16, 2022
SELL
$8.44 - $12.49 $180,565 - $267,211
-21,394 Reduced 29.12%
52,082 $452,000
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $346,610 - $481,897
34,250 Added 87.31%
73,476 $831,000
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $278,726 - $508,627
-38,445 Reduced 49.5%
39,226 $493,000
Q2 2021

Aug 11, 2021
BUY
$8.0 - $9.75 $84,048 - $102,433
10,506 Added 15.64%
77,671 $631,000
Q1 2021

May 17, 2021
SELL
$8.63 - $10.94 $541,178 - $686,036
-62,709 Reduced 48.28%
67,165 $621,000
Q4 2020

Feb 16, 2021
BUY
$8.3 - $13.59 $58,979 - $96,570
7,106 Added 5.79%
129,874 $1.26 Million
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $301,032 - $392,940
26,640 Added 27.71%
122,768 $1.52 Million
Q1 2020

May 15, 2020
BUY
$8.0 - $15.48 $362,800 - $702,018
45,350 Added 89.31%
96,128 $976,000
Q3 2019

Nov 14, 2019
BUY
$16.02 - $22.47 $813,463 - $1.14 Million
50,778 New
50,778 $853,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $69.5M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email